Live tape
Top 8, mentions 7d9,266TSLA1,965 mentions▲ +0.05GOOGL1,515 mentions▲ +0.05NVDA1,138 mentions▲ +0.07CRWV1,023 mentions▲ +0.04SPCX1,015 mentions▲ +0.07QQQ1,006 mentions▲ +0.04META827 mentions▲ +0.05NBIS777 mentions▲ +0.05

Equity · Healthcare

NVST

NYSE

Envista Holdings Corporation

$24.98 +0.95% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Sep 16, 2026
Price · Chart
26 sessions
$30 $24 11 Aug 16 Sep

The line runs $28.52 on 11 August through $24.98 on 16 September, on a scale from $24 to $30. Days the market did not trade hold the previous close, flat.

Market cap $4.0B
P/E (TTM) 43.1
52-week range $19 – $30.17
Avg volume 256.8K

as of Sep 16, 2026

NVST insider trades

SEC Form 4 · last 90 days · newest reported trade 20 Aug 2026
Open-market buys 0
Open-market sells 1
Net sold $220K
Non-trade filings 5
Date Insider Type Shares Value
20 Aug 2026 Reis Mischa SVP, Strategy & Bus. Dev. Sell 8,000 $220K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
25 Aug 2026 Acurio Veronica President, Orthodontics Tax withheld 7,710 $212K
25 Aug 2026 Befidi Robert President, Diagnostics Tax withheld 5,147 $141K
25 Aug 2026 Hammes Eric D. Chief Financial Officer Tax withheld 10,885 $299K
25 Aug 2026 Nilsson Stefan President, Nobel Biocare Tax withheld 804 $22K
18 Aug 2026 Keel Paul A Chief Executive Officer Award 179,730

NVST reported financials

SEC EDGAR XBRL SEC EDGAR

NVST reported revenue of $2.7B for the fiscal year ended 31 Dec 2025. Net income over the same period was $47.0M.

Figure Reported Period
Revenue $2.7B 31 Dec 2025 fiscal year
Net income $47.0M 31 Dec 2025 fiscal year
Diluted EPS $0.28 31 Dec 2025 fiscal year
Total assets $5.6B 03 Jul 2026 at period end
Total equity $3.1B 03 Jul 2026 at period end

NVST earnings

SEC EDGAR
Date Period EPS Revenue
03 Jul 2026 Q2 2026 $0.33 —
03 Apr 2026 Q1 2026 $0.23 —
31 Dec 2025 FY 2025 $0.28 —
26 Sep 2025 Q3 2025 −$0.18 —
27 Jun 2025 Q2 2025 $0.16 —
28 Mar 2025 Q1 2025 $0.10 —
31 Dec 2024 FY 2024 −$6.50 —
27 Sep 2024 Q3 2024 $0.05 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

NVST institutional holders

SEC Form 13F SEC EDGAR

10 of the 45 institutional funds we track reported a NVST position for the quarter ended 30 Jun 2026 — a combined $238.8M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
AQR Capital Management Added +53.7% shares 4,023,691 $106.0M
Point72 Asset Management New position 1,563,395 $41.2M
Renaissance Technologies Added +25.9% shares 1,520,565 $40.1M
Millennium Management New position 1,147,047 $30.2M
Marshall Wace Added +2,939.0% shares 330,456 $8.7M
D. E. Shaw & Co. Added +1,223.0% shares 228,766 $6.0M
Two Sigma Investments Held (±25%) +6.8% shares 134,700 $3.5M
Citadel Advisors Trimmed −98.8% shares 56,836 $1.5M
Bridgewater Associates Trimmed −45.5% shares 41,647 $1.1M
Man Group Trimmed −69.8% shares 14,330 $378K

NVST fails-to-deliver

SEC CNS data SEC

On 25 Sep 2026, 4,741 shares of NVST failed to deliver (about $114K).

Settlement date Shares failed Notional % of shares out
25 Sep 2026 4,741 $114K 0.003%
23 Sep 2026 227 $5K <0.001%
21 Sep 2026 99 $2K <0.001%
18 Sep 2026 58 $1K <0.001%
17 Sep 2026 4,993 $125K 0.003%
16 Sep 2026 188 $5K <0.001%
14 Sep 2026 855 $22K 0.001%
09 Sep 2026 224 $6K <0.001%

Congressional trades in NVST

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in NVST is a sale by Pete Sessions (house, TX), dated 06 Jun 2024.

Date Member Type Amount
06 Jun 2024 filed 06 Jun 2024 Pete Sessions house · Republican–TX Sale $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 03 Jul 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings